PureTech Health plc (LON:PRTC – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 138.75 ($1.86) and last traded at GBX 140.10 ($1.87), with a volume of 855201 shares trading hands. The stock had previously closed at GBX 141.40 ($1.89).
PureTech Health Stock Down 0.9 %
The stock has a fifty day simple moving average of GBX 160.42 and a two-hundred day simple moving average of GBX 193.20. The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 47.27. The firm has a market cap of £335.43 million, a PE ratio of -609.14 and a beta of 1.02.
About PureTech Health
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
- Five stocks we like better than PureTech Health
- How to Use Stock Screeners to Find Stocks
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- Retail Stocks Investing, Explained
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- With Risk Tolerance, One Size Does Not Fit All
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
